{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T07:57:55Z","timestamp":1574495875112},"reference-count":12,"publisher":"Wiley","issue":"4","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":883,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1111\/cen.12188","type":"article-journal","created":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T17:13:29Z","timestamp":1362244409000},"page":"499-503","source":"Crossref","is-referenced-by-count":18,"title":"Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis","prefix":"10.1111","volume":"79","author":[{"given":"Polyzois","family":"Makras","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetes; 251 Hellenic Air Force & VA General Hospital; Athens; Greece"}]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[{"name":"Second Medical Clinic; Ippokration Hospital; Aristotle University of Thessaloniki; Thessaloniki; Greece"}]},{"given":"Athanasios","family":"Papatheodorou","sequence":"additional","affiliation":[{"name":"Department of Medical Research; 251 Hellenic Air Force and VA General Hospital; Athens; Greece"}]},{"given":"Panagiotis","family":"Kokkoris","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Chatzifotiadis","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine; 251 Hellenic Air Force and VA General Hospital; Athens; Greece"}]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[{"name":"Department of Endocrinology; 424 Military Hospital; Thessaloniki; Greece"}]}],"member":"311","published-online":{"date-parts":[[2013,4,1]]},"reference":[{"key":"10.1111\/cen.12188-BIB0001|cen12188-cit-0001","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/TCRM.S24239","article-title":"Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab","volume":"8","author":"Anastasilakis","year":"2012","journal-title":"Therapeutics and Clinical Risk Management"},{"key":"10.1111\/cen.12188-BIB0002|cen12188-cit-0002","doi-asserted-by":"crossref","first-page":"28164","DOI":"10.1074\/jbc.M110.101964","article-title":"Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL","volume":"285","author":"Pierroz","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"10.1111\/cen.12188-BIB0003|cen12188-cit-0003","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/cen.12188-BIB0004|cen12188-cit-0004","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/cen.12188-BIB0005|cen12188-cit-0005","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/jbmr.81","article-title":"Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate","volume":"25","author":"Seeman","year":"2010","journal-title":"Journal of Bone and Mineral Research"},{"issue":"Suppl 1","key":"10.1111\/cen.12188-BIB0006|cen12188-cit-0006","first-page":"S1","article-title":"The Transitory increase in PTH Following Denosumab Administration is Associated with Reduced Intracortical Porosity: a Dinstictive Attribute of Denosumab Therapy","volume":"26","author":"Seeman","year":"2011","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/cen.12188-BIB0007|cen12188-cit-0007","doi-asserted-by":"crossref","first-page":"83","DOI":"10.14310\/horm.2002.1225","article-title":"Medical treatment of hypercalcaemia","volume":"8","author":"Makras","year":"2009","journal-title":"Hormones (Athens)"},{"key":"10.1111\/cen.12188-BIB0008|cen12188-cit-0008","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jbmr.251","article-title":"Effects of denosumab on bone turnover markers in postmenopausal osteoporosis","volume":"26","author":"Eastell","year":"2011","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/cen.12188-BIB0009|cen12188-cit-0009","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jbmr.1479","article-title":"Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension","volume":"27","author":"Papapoulos","year":"2012","journal-title":"Journal of Bone and Mineral Research"},{"issue":"Suppl 1","key":"10.1111\/cen.12188-BIB0010|cen12188-cit-0010","first-page":"S1","article-title":"The effects of combined Denosumab and Teriparatide administration on bone mineral density in postmenopausal women: the DATA (Denosumab And Teriparatide Administration) Study","volume":"27","author":"Leder","year":"2012","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/cen.12188-BIB0011|cen12188-cit-0011","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/jbmr.238","article-title":"Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis","volume":"26","author":"Cosman","year":"2011","journal-title":"Journal of Bone and Mineral Research"},{"issue":"342","key":"10.1111\/cen.12188-BIB0012|cen12188-cit-0012","doi-asserted-by":"crossref","first-page":"d2040","DOI":"10.1136\/bmj.d2040","article-title":"Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis","volume":"19","author":"Bolland","year":"2011","journal-title":"BMJ"}],"container-title":"Clinical Endocrinology","original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcen.12188","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T08:38:30Z","timestamp":1498034310000},"score":1.0,"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":12,"journal-issue":{"published-print":{"date-parts":[[2013,10]]},"issue":"4"},"URL":"http:\/\/dx.doi.org\/10.1111\/cen.12188","relation":{"cites":[]},"ISSN":["0300-0664"],"subject":["Endocrinology, Diabetes and Metabolism"],"container-title-short":"Clin Endocrinol"}